U.S. IPO Weekly Recap: ORIC Pops 61% And SPACs Make A Comeback [Seeking Alpha]
Oric Pharmaceuticals, Inc. (ORIC)
Company Research
Source: Seeking Alpha
SummaryThe IPO market saw a jump in activity as one biotech and three SPACs went public this past week.The durability of the biotech industry was demonstrated once again, with ORIC Pharmaceuticals popping 61% on its first day.After a month-long blank check hiatus, three SPACs completed public offerings this past week.The IPO market saw a jump in activity as one biotech and three SPACs went public this past week. The durability of the biotech industry was demonstrated once again, with ORIC Pharmaceuticals (Oncology biotech ORIC Pharmaceuticals priced its twice-upsized IPO at the high end to raise $120 million at a $493 million fully diluted market cap (+16% vs. original midpoint). Led by experienced executives from Ignyta, ORIC is developing an oral GR antagonist in two Phase 1b trials as combination therapies for prostate cancer and advanced or metastatic solid tumors. The company believes its $201 million in post-IPO cash will last into late 2022, but it will require additional fundi
Show less
Read more
Impact Snapshot
Event Time:
ORIC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ORIC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ORIC alerts
High impacting Oric Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ORIC
News
- ORIC® Pharmaceuticals to Participate in Upcoming Investor ConferencesGlobeNewswire
- ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $20.00 price target on the stock.MarketBeat
- ORIC® Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational UpdatesGlobeNewswire
- ORIC® Pharmaceuticals to Participate in Upcoming Investor ConferencesGlobeNewswire
- ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $21.00 price target on the stock.MarketBeat
ORIC
Earnings
- 11/12/24 - Miss
ORIC
Sec Filings
- 12/17/24 - Form 4
- 12/17/24 - Form 4
- 12/17/24 - Form 4
- ORIC's page on the SEC website